BARCELONA, Spain, June 17, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), one of the world’s leading producers of plasma-derived medicines, today announced that Biotest, a Grifols ...
Good's syndrome is a rare, adult-onset immunodeficiency characterised by the presence of a thymoma alongside hypogammaglobulinaemia and profound alterations in both humoral and cellular immunity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback